According to a new analysis by Growth Plus Reports, the global medical videoscopes market is estimated to be worth US$ 33.82 billion by 2030, with a revenue CAGR of 7.0%. The study examines the key strategies, factors and prospects, competitive landscape, evolving industry patterns, market size, financial information and forecasts, and potential business opportunities.
Key Takeaways:
- The increasing prevalence of chronic diseases that require endoscope procedures will drive market growth.
- The growing demand for bariatric surgery for weight reduction will support market revenue growth.
- North America will dominate the global market with the largest revenue share.
Request a Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/medical-videoscopes-market/7884
Medical Videoscopes Market Scope
| Report Attribute | Details |
| Market size value in 2021 | US$ 18.4 billion |
| Revenue forecast in 2030 | US$ 33.82 billion |
| Growth Rate | CAGR of 7% from 2022 to 2030 |
| Base year for estimation | 2021 |
| Forecast period | 2022-2030 |
| Segments covered | Product, Application, and Region. |
| Regional scope | North America, Europe, Asia Pacific, and the Rest of the World (ROW) |
Market Drivers
The rising preference for minimally invasive procedures is the primary factor driving the revenue growth of the medical videoscopes market. Furthermore, the increased prevalence of diseases requiring endoscopies, the low cost of endoscope procedures, the increasing geriatric and obese population, and favorable reimbursement policies are expected to contribute to market revenue growth. Besides this, the adoption of advanced technologies, the incorporation of high-resolution technologies, and the miniaturization of endoscopes will boost market revenue growth.
Market Segmentation
Growth Plus Reports has analyzed the global medical videoscopes market from four perspectives: Product, Application, and Region.
Product Segmentation: Based on the product, the medical videoscopes market is segmented into visualization systems and video endoscopes. The visualization system segment dominates the market with the largest revenue share because of the use of advanced technological systems such as HD 3-chip cameras, 360-degree, 3D imaging systems, and ultra-high-definition LED multi-light technology, as well as a wide range of applications that provide video assisting in surgical procedures such as thoracic, anterior, and posterior spinal surgeries, bariatric, and general endoscopic procedures.
Application Segmentation: Based on the application, the medical videoscopes market is segmented into laparoscopy, arthroscopy, obstetrics/gynecology, gastrointestinal (GI) endoscopy, urology endoscopy (cystoscopy), bronchoscopy, mediastinoscopy, otoscopy, laryngoscopy, and others. The laparoscopy segment dominates the market with the largest revenue share because of the increasing use of laparoscopy in various surgeries, the growing obese population, the growing demand for bariatric surgery for weight reduction, and the growing preference for minimally invasive procedures.
Regional Growth Dynamics
Based on the region, the global medical videoscopes market is segmented into North America, Europe, Asia Pacific, and the Rest of the World.
North America dominates the global medical videoscopes market with the largest revenue share. The rising prevalence of cancer and orthopedic, gastrointestinal, and ophthalmic diseases, the adoption of advanced technologies, advanced healthcare infrastructure, the increased demand for minimally invasive procedures, and the presence of top market players in the region are the major factors responsible for North America’s significant revenue share in the global market.
Request for Customization – https://www.growthplusreports.com/inquiry/customization/medical-videoscopes-market/7884
Competitive Landscape
The following companies are important players in the global medical videoscopes market:
- Olympus Corporation
- Stryker Corporation
- Fujifilm Holding Corporation
- KARL STORZ GmbH & Co. KG
- ConMed Corporation
- Pentax Medical System (Hoya Corporation)
- Smith and Nephew; Plc.
- Medtronic; Plc
- Arthrex; Inc
- Welch Allyn; Inc.
- XION GmbH
- US Endoscopy
- Richard Wolf GmbH
There is moderate competition in the medical videoscopes market. To introduce novel products, the major players in the market emphasize research and development. Major companies often engage in mergers and acquisitions to enhance their market share.
Recent developments:
- Olympus Corporation announced the launch of their VISERA ELITE III surgical visualization platform in September 2020. It offers various imaging capabilities supported by a single system, allowing for minimally invasive procedures such as laparoscopic colectomy and laparoscopic cholecystectomy.
- Fujifilm obtained regulatory clearance in September 2020 for its latest generation Endoscopic Ultrasound endoscope (EG-740UT) combined with the ARIETTA 850 FF ENDO for the upper gastrointestinal tract.
Table of Content
- INTRODUCTION
- Market Ecosystem
- Timeline Under Consideration
- Historical Years – 2020
- Base Year – 2021
- Forecasted Years – 2022 to 2030
- Currency Used in the Report
- RESEARCH METHODOLOGY
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
- PREMIUM INSIGHTS
- Current Market Trends (COVID-19 Perspective)
- Key Players & Competitive Positioning (2021)
- MARKET DYNAMICS
- Drivers
- Restraints/Challenges
- Opportunities
Buy this Premium Research Report: https://www.growthplusreports.com/checkout-7884
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market
CUSTOMIZATION OPTIONS:
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- ‘Business Profile’ of Key Players
Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction
Visit our report store at – https://www.growthplusreports.com/report-store
Browse related reports:
Pharmaceutical Lipids Market by Product (Triglycerides, Phospholipids, Sphingolipids, Cholesterol, Fatty Acids), Source (Synthetic, Semi-synthetic, And Natural), Form (Liquid, Semi-solid, Solid), Application (Conventional Lipid-Based Drug Delivery Systems, Self-Emulsifying Drug Delivery Systems, Self-Microemulsifying Drug Delivery Systems, Liposomes, Solid Lipid Nanoparticles & Nanostructured Lipid Carriers), and End-user (Biopharmaceutical Companies, Contract Research Organizations, Academics & Research Institutes) – Global Outlook & Forecast 2022-2030
Contract Development and Manufacturing Organization (CDMO) Market By Service (Contract Manufacturing Organization (CMO) and Contract Research Organization (CRO)) – Global Outlook & Forecast 2022-2030
Heparin Market By Product Type (Low Molecular Weight Heparin (LMWH) and Unfractionated Heparin (UFH)), By Source (Porcine and Bovine), By Application (Heart Attacks, Stroke, Deep Vein Thrombosis & Pulmonary Embolism, Atrial Fibrillation, and Others), By End User (Hospitals & ASCs, Clinics, and Others) – Global Outlook & Forecast 2022-2030
Neuromodulation Devices Market by Technology (Internal Neuromodulation, External Neuromodulation), by Application (Spinal cord stimulation, Deep Brain Stimulation, Vagus nerve stimulation) – Global Outlook & Forecast 2022-2030
Allergic Bronchopulmonary Aspergillosis Therapeutics Market by Drug Class (Azoles, Antibiotics, Corticosteroids), and by Route of Administration (Oral, Parenteral, Inhalation) – Global Outlook & Forecast 2022-2030
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.
Contact:
Manan Sethi
Director, Market Insights
Email: sales@growthplusreports.com
256 Chapman Road
STE 105-4, Newark,
New Castle – 19702, USA
Phone no: +1 888 550 5009
Web: https://www.growthplusreports.com/